“The microchip-based implant is truly at the intersection of digital technology and medicine and...
Pursuant to the agreement, Arrowhead will acquire all shares of BTMI from the BTMI shareholders...
The acquisition further diversifies Tribute's product portfolio in Canada through the addition of 13 marketed and two pipeline products.
Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as "double chin".
DHL highlights some critical challenges facing the pharmaceutical industry as global demand for expensive, structurally complex and temperature-sensitive biologics and specialty drugs grows.
Prescription drug sales are forecasted to grow nearly 5% annually over the next five years.
See which products rose to the top of this year's list.
One driver for the company's success is the increased emphasis on strategic partnerships with manufacturers.
Dr. Donna Nelson, the former scientific advisor to the hit-show “Breaking Bad” and president-elect of the American Chemical Society talks Hollywood, making meth, and the most urgent issue facing the chemical industry.
Deloitte's report suggests that biopharmaceutical companies could have greater success if they collaborate with other organizations — even competitors — as part of an open innovation approach to research and development.
The combination of Allergan and Actavis created one of the world's top 10 pharmaceutical companies by revenue and a leader in a new industry model.
The plans include the construction of a new 30,000 square foot, state-of-the-art, fully GMP-compliant cleanroom facility.
Walgreens Boots Alliance, Inc. is recalling a line of women's multivitamins because the packaging is not child-resistant.
ITP affects as many as 5 in 100,000 children each year and is characterized by a low platelet count.
Attorneys for a Georgia woman on death row say apparent uncertainty about what caused cloudiness in a lethal injection drug strengthens their argument that she not be put to death until a judge determines her rights won't be violated.
South Korea reported a 10th death from the MERS virus on Thursday, although officials say they believe the disease has peaked.
The AIDS industry and its government allies were just waiting for evidence to justify a change in policy.
Reltio has released the findings of a new study that dramatically illustrates the life sciences industry's move toward optimizing the use of data.
Dougherty County District Attorney Greg Edwards dismissed a malice murder charge against 23-year-old Kenlissia Jones, who spent about three days in jail after seeking help at a hospital.
Carna Biosciences today announced a worldwide licensing agreement with Janssen Biotech to further develop and commercialize compounds from one of Carna Bioscience’s small molecule protein kinase inhibitor programs.
It's the healthcare giant's first project under its ambitious initiative to prevent or at least intercept and reduce harm from many diseases.
When present in pharmaceutical products, pyrogenic substances can prove harmful to humans by causing life threatening fevers. Therefore, testing of pharmaceutical products for pyrogens is critical to ensure patient safety.
The program focused on a next generation selective glucocorticoid receptor antagonist in development for the treatment of Cushing’s syndrome and certain cancers.
The CDMO unveiled initiatives that include additional staff for daily clinical manufacturing operations, as well as the doubling of capacities for performing visual inspection and in-process control.
"The demand for our characterization services from North and South America has also been strong," said BioPharmaSpec Founder and President Professor Howard R. Morris.
RecAP is currently in Phase II development for testing the potential treatment of acute kidney injury, with the potential to be developed for hypophosphatasia.
The woman has an extremely drug-resistant form of the disease, which is impervious to most TB drugs.
- Page 1